201 related articles for article (PubMed ID: 34893580)
1. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
Ruhl L; Pink I; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer A; Boblitz L; Schmidt J; David S; Jäck HM; Roth E; Cornberg M; Schulz TF; Welte T; Höper MM; Falk CS
Signal Transduct Target Ther; 2021 Dec; 6(1):418. PubMed ID: 34893580
[TBL] [Abstract][Full Text] [Related]
2. Laboratory biomarkers and prognosis in Covid-19, where do we stand?
Israni A; Goulden CJ; Harky A
Rev Med Virol; 2021 Nov; 31(6):e2296. PubMed ID: 34516018
[No Abstract] [Full Text] [Related]
3. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.
Chen Q; Yu B; Yang Y; Huang J; Liang Y; Zhou J; Li L; Peng X; Cheng B; Lin Y
Int Immunopharmacol; 2021 Aug; 97():107685. PubMed ID: 33951560
[TBL] [Abstract][Full Text] [Related]
4. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
Acevedo N; Escamilla-Gil JM; Espinoza H; Regino R; Ramírez J; Florez de Arco L; Dennis R; Torres-Duque CA; Caraballo L
Front Immunol; 2021; 12():678661. PubMed ID: 34335580
[TBL] [Abstract][Full Text] [Related]
5. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
6. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
7. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
Kong Y; Wang Y; Wu X; Han J; Li G; Hua M; Han K; Zhang H; Li A; Zeng H
Signal Transduct Target Ther; 2020 Sep; 5(1):192. PubMed ID: 32895366
[No Abstract] [Full Text] [Related]
8. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Xi Y
Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
[No Abstract] [Full Text] [Related]
9. Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.
Gao C; Zhu L; Jin CC; Tong YX; Xiao AT; Zhang S
Clin Immunol; 2020 Dec; 221():108611. PubMed ID: 33068796
[TBL] [Abstract][Full Text] [Related]
10. Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses.
Kwon JS; Kim JY; Kim MC; Park SY; Kim BN; Bae S; Cha HH; Jung J; Kim MJ; Lee MJ; Choi SH; Chung JW; Shin EC; Kim SH
Am J Trop Med Hyg; 2020 Dec; 103(6):2412-2418. PubMed ID: 33124544
[TBL] [Abstract][Full Text] [Related]
11. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
[No Abstract] [Full Text] [Related]
12. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
[TBL] [Abstract][Full Text] [Related]
14. Immune dysregulation and system pathology in COVID-19.
Jamal M; Bangash HI; Habiba M; Lei Y; Xie T; Sun J; Wei Z; Hong Z; Shao L; Zhang Q
Virulence; 2021 Dec; 12(1):918-936. PubMed ID: 33757410
[TBL] [Abstract][Full Text] [Related]
15. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
[TBL] [Abstract][Full Text] [Related]
16. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
[TBL] [Abstract][Full Text] [Related]
17. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
Song NJ; Allen C; Vilgelm AE; Riesenberg BP; Weller KP; Reynolds K; Chakravarthy KB; Kumar A; Khatiwada A; Sun Z; Ma A; Chang Y; Yusuf M; Li A; Zeng C; Evans JP; Bucci D; Gunasena M; Xu M; Liyanage NPM; Bolyard C; Velegraki M; Liu SL; Ma Q; Devenport M; Liu Y; Zheng P; Malvestutto CD; Chung D; Li Z
J Hematol Oncol; 2022 Jan; 15(1):5. PubMed ID: 35012610
[TBL] [Abstract][Full Text] [Related]
18. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.
Ghasemzadeh M; Ghasemzadeh A; Hosseini E
Hum Immunol; 2022 Jan; 83(1):86-98. PubMed ID: 34583856
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
20. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
